PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 48: Articles 23501-24000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Shift of emphasis in the allocation of resources: a new policy of the International Planned Parenthood Federation.
  2. Short term relationship counseling: a self instructional manual for use in family planning clinics. Rev. ed.
  3. Sister chromatid exchanges in women taking oral contraceptive tablet norethindroni compositae for a long term.
  4. Smoking and oral contraception in cancer of the cervix [letter]
  5. Smoking, oral contraceptives, and thromboembolic disease.
  6. Socialization for sexual and contraceptive behavior: moral absolutes versus relative consequences.
  7. The socio-cultural context for population and family planning in sub-Saharan Africa.
  8. Socio-demographic correlates of the decision process for medical termination of pregnancy and family planning.
  9. Socio-economic factors and contraception in India: a multivariate approach.
  10. Some biochemical effects of long term oral contraceptive therapy on Egyptian females living in rural areas.
  11. Some cautions in the use and interpretation of regression analysis for the evaluation of family planning programmes.
  12. Some critical unsolved issues in the measurement of the impact of family planning programmes on fertility.
  13. Some facts concerning injectable contraceptives: memorandum of a World Health Organization meeting. [Quelques faits concernant les contraceptifs injectables: memorandum sur une reunion de l'OMS.]
  14. Sperm enzyme inhibitors for vaginal and other contraception.
  15. Splenic artery thrombosis secondary to oral contraceptive medication: case report.
  16. Sri Lanka current use of contraception: patterns and determinants.
  17. The Sri Lanka oral contraceptive and vitamin study, AID/pha-C-1191, final report.
  18. Staffing a contraceptive service for adolescents: the importance of sex, race, and age.
  19. State-run family planning in Victoria.
  20. Statement and resolution concerning the Bureau of Maternity Services and Family Planning of New York City.
  21. Statement on injectable contraception.
  22. Statement on periodic abstinence for family planning.
  23. Status of family planning among the patients visiting our clinic.
  24. Sterilisation: services, organisation, procedures. Proceedings of a conference organised by the Birth Control Trust at the Royal Society of Medicine, London on 3 November 1982.
  25. Steroidal contraception and the immune system. [Steroidni kontraceptiva a imunitni system.]
  26. Stopping rules for family planning in an oriental society.
  27. Strategies for the development of a family planning program. Administration applied to a social problem: the focus on systems. [Estrategias para el desarrollo de un programa de planificacion familiar. La administracion aplicada a un problema social: enfoque de sistemas.]
  28. A strategy for birth control based on population trends.
  29. Strategy on control of births by population trend (author's transl)
  30. Studies of the attitude of a group of puerperas of the Brianza region toward contraception and the services offered for such purposes by the public health organization. [Indagine sull'atteggiamento di un gruppo di puerpere della brianza nei riguardi della contraccezione e delle prestazioni offerte a tal fine dalle strutture pubbliche.]
  31. Studies on inhibitors of blood coagulation and fibrinolysis during use of oral contraceptives.
  32. A study of adolescent attitudes toward sexuality, contraception and pregnancy.
  33. A study of family planning among Muslims at Akurana P.U.
  34. Study of plasma renin activity in Indian women using low estrogen combination pill as contraceptive [abstract]
  35. A study of the drop outs in the family planning programme of the Family Planning, Maternal and Child Health Division, Ministry of Health.
  36. A study of the feasibility of contraceptive prevalence programming in Morocco.
  37. A study of women's attitudes toward contraceptive alternatives.
  38. Subsidized family planning services in Texas.
  39. The Sudan Community Based Health and Family Planning Project: description of a training course.
  40. Suggestions on evaluation tools and indications for assessing performance of TBAs in family planning programmes.
  41. Surgical contraception in a rural area in southern Sri Lanka.
  42. Surgical contraception in business and industry.
  43. Surgical contraception in Pakistan.
  44. Survey of marital status and family planning of schizophrenics.
  45. Survey of media receptivity to contraceptive advertising.
  46. Surveys and their use in family planning analysis.
  47. Synthesis of the teaching cycle on contraception: contraception consultations. [Synthese du cycle d'enseignement sur la contraception: les consultations de contraception.]
  48. Systemic Actinomyces infection. A potential complication of intrauterine contraceptive devices.
  49. Taking the initiative: a green light for contraceptive responsibility?
  50. A teaching model to simulate the demographic effects of health and family planning programs in Nepal.
  51. Teaching natural family planning: a guide for fieldworkers.
  52. Teenage contraceptive use and services in Scandinavia.
  53. Teenage women and contraceptive behavior: focus on self-efficacy in sexual and contraceptive situations.
  54. The teenager and the gatekeeper: organizations, professionals, and contraceptive outcomes.
  55. Teratogenic hazards of oral contraceptives [letter]
  56. Terminology and core curricula in natural family planning.
  57. Terminology and core curricula in natural family planning.
  58. Tetracycline and oral contraceptives [letter]
  59. The tetracycline--oral contraceptive controversy.
  60. Thailand: National Family Planning Programme (NFPP). An overview.
  61. A theoretical framework for studying adolescent contraceptive use.
  62. Therapy of side effects of oral contraceptive agents with vitamin B6.
  63. The third S.K. and F. prize lecture, University of London, December 1981. The clinical pharmacology of oral contraceptive steroids.
  64. Thrombin-induced platelet malondialdehyde (MDA) formation in normal subjects and in women taking oral contraceptives.
  65. Thyroid function tests under the effect of steroidal contraceptives compared to normal pregnancy.
  66. To develop the family planning work deeply through following the working method of "taking three as the keys".
  67. To grasp the family planning program early, carefully and surely according to the law of reproduction.
  68. To raise the family planning work to a new level--a comprehensive introduction to the National Family Planning Working Conference.
  69. Topical contraceptives. [Mestnye Kontraseptivy.]
  70. Toward a male contraceptive [letter]
  71. Toward a male contraceptive [reply to letter of Judi S. Morrill] [letter]
  72. Toward a taxonomy of contraceptive behaviors and attitudes of single college men.
  73. Toxic shock syndrome associated with a contraceptive diaphragm.
  74. Toxicological and serendipitous leads to male contraception.
  75. Traditional attitudes and change receptivity in family planning. Interim report submitted to the Ghana National Family Planning Programme.
  76. Training consultation to the Cairo Family Planning Association, Egypt.
  77. Training manual for Natural Family Planning and Fertility Awareness Method Instructors Training Program. Revised ed.
  78. The training of community leaders and their utilization in family planning programs. [El entrenamiento de lideres comunitarious y su utilizacion en programas de planificacion familiar.]
  79. The training of workers for community-based family planning and health projects.
  80. Training village workers for family planning and health interventions.
  81. Tranexamic acid, intrauterine contraceptive devices and fatal cerebral arterial thrombosis.
  82. Treatment of recurrent toxic shock syndrome with oral contraceptive agents.
  83. Trends in adolescent contraception, pregnancy, and childbearing.
  84. Trends in contraceptive practice: United States, 1965-76.
  85. Trials of the ovulation method of natural family planning.
  86. Trip report: initial preparation for a contraceptive social marketing program in Costa Rica, San Jose, Costa Rica, December 12-17, 1982.
  87. Tuboovarian actinomycosis in women using contraception by means of intrauterine devices of the type DANA (author's transl) [Tuboovarialna aktinomykoza u zien pouzivajucich antikoncepciu pomocou intrauterinneho telieksa typu DANA.]
  88. Two problems in oral contraception: arteriosclerotic cardiopathy and drug interactions.
  89. The two-edged scimitar: integration issues for family planning and health in Tunisia.
  90. Ultrasound diagnosis of multiple anomalies associated with prenatal oral contraceptives.
  91. UNFPA allocations for contraceptives as of 31 December 1981 [tables]
  92. Unmarried black adolescent fathers' attitudes toward abortion, contraception, and sexuality: a preliminary report.
  93. The unmet need for birth control in Malaysia.
  94. The unmet need for contraception in Thailand.
  95. Unmet need for contraception in World Fertility Surveys of developing countries.
  96. The unmet need for family planning in Indonesia.
  97. The use of contraceptive methods in Puerto Rico: some recent trends. [El uso de metodos anticonceptivos en Puerto Rico: tendencias recientes.]
  98. Use of contraceptive methods in Puerto Rico: recent trends. [El uso de metodos anticonceptivos en Puerto Rico: tendencias recientes.]
  99. The use of contraceptive prevalence survey data to evaluate family planning program service statistics.
  100. Use of contraceptive prevalence surveys to evaluate maternal-child health/family planning programs [tables]
  101. The use of intrauterine contraceptive devices in diabetics.
  102. Use of linear programming for family planning target setting.
  103. Use of maternal-child health services and current use of contraception in northeast Brazil [tables]
  104. The use of nurse practitioners for the provision of family planning services in Egypt.
  105. Use of statistical procedure to evaluate intrauterine contraception. [Aplicacion de un procedimiento estadistico para evaluar la anticoncepcion intrauterina.]
  106. Use of the "efficiency model" in family planning programs: a response to the new federalism.
  107. The use of the observation technique for qualitative evaluation of health and family planning programmes: some experiences.
  108. The use of vasectomy as a family planning method in India (past and present)
  109. Users of the contraceptive pill in Daveyton (first report) [Gebruikers van die kontraseptiewe pil in Daveyton (eerste verslag)]
  110. Uterine leiomyomas, serum cholesterol, and oral contraceptives. A preliminary study of epidemiologic differences in Los Angeles, California and Albany, New York.
  111. Utilisation and training methodologies for traditional birth attendants related to National Family Planning Programme.
  112. Vaginal contraception in 1982. Realities and perspectives (author's transl) [La contraception vaginale en 1982. Realities et perspectives.]
  113. Vaginal contraception--an update.
  114. Vaginal contraception.
  115. Vaginal topical chemical contraception with C-film. [Contraccezione chimica topica vaginale con C-film.]
  116. The value of children and the costs of contraception: predictors of reproductive ideals and contraceptive practice in Egypt.
  117. The value of education in a total family planning program.
  118. Vascular thrombosis related to oral contraceptives and antiethinylestradiol antibodies--epidemiology and prevention (author's transl) [Accidents vasculaires des contraceptifs oraux et anticorps anti-ethinyl-oestradiol. Epidemiologie et prevention.]
  119. Ventilatory response of humans to chronic contraceptive pill administration.
  120. Village volunteers for family planning: some recent experiences in the district of Kurunegala, (Sri Lanka)
  121. VLI's 2day OTC vaginal contraceptive sponge recommended for approval.
  122. Voluntary surgical contraception in the Philippines.
  123. Voluntary surgical contraception--acceptance and new dimensions.
  124. What does it take to develop a new contraceptive?
  125. What rules are imposed on women with regard to medical contraception. [Quelles regles se sont imposees aux femmes a travers la contraception medicalisee?]
  126. What's new in contraceptives?
  127. When patients ask about the latest and safest oral contraceptive.
  128. Who is practicing family planning? Comparing survey and clinic reports in Bohol, Philippines.
  129. WHO Programme in Maternal and Child Health and Family Planning. First Meeting of the Programme Advisory Committee, Geneva, 14-18 June 1982.
  130. Will consumption of oral contraceptives enhance the gastrointestinal absorption of lead?
  131. Women who use organized family planning services: United States, 1979.
  132. Women's role and status in family planning.
  133. Women's status and family planning in Haiti.
  134. The world of work and information about contraception. [Le monde du travail et l'information a la contraception.]
  135. World population trends and their significance for contraceptive research.
  136. Yugoslav migrants and family planning.
  137. Zaire Family Planning Operations Research Project: 18-month progress report, November 1980-March 1982.
  138. Zomepirac sodium, 100 in the treatment of pain and expulsion associated with the use of an intrauterine contraceptive device.
  139. Intracervical release of levonorgestrel for contraception.
  140. Intrauterine contraception with Nova-T and Copper-T-200 during three years.
  141. Access to data and the information explosion: oral contraceptives and the risk of cancer.
  142. Alternative measures of unmet need for family planning in developing countries.
  143. An analysis of continuity-discontinuity in natural family planning: an Australian factor analysis.
  144. Abortion for failed contraception. [Letter]
  145. Abortions preventable by contraceptive practice.
  146. Acceptability of the contraceptive vaginal ring by rural and urban population in two Latin American countries.
  147. Antecedents to contraceptive innovation: evidence from rural Northern Thailand.
  148. Avoidance of the dimensional incompatibility as the main reason for side effects in intrauterine contraception.
  149. Bacteriological colonisation of uterine cavity: role of tailed intrauterine contraceptive device.
  150. Behaviour of butanol-extractable jodine in serum, during and after long-time application of hormonal contraceptives (author's transl) [Zum Verhalten von butanolextrahierbarem Jod (BEJ) im Serum wahrend und nach Langzeitapplikation hormonaler Kontrazeptiva.]
  151. Behaviour of Ujoviridin exposure test (ICG) in conjunction with application of hormonal contraceptives (author's transl) [Das Verhalten des Ujoviridin-(ICG)-Belastungstests unter der Applikation hormonaler Kontrazeptiva.]
  152. Blood levels of ethynylestradiol, caffeine, aldosterone and desoxycorticosterone in hypertensive oral contraceptive users.
  153. Breast cancer: the role of the family planning clinic.
  154. Breastfeeding and contraceptive patterns postpartum: a study in South Lebanon.
  155. The Calabar Rural Maternal and Child Health/Family Planning Project.
  156. Cancer in women who have taken contraceptive steroids.
  157. A case-control study of the possible association between oral contraceptives and malignant melanoma.
  158. Changes in insulin receptors during oral contraception.
  159. Changing profile of IUD users in family planning clinics in rural Bangladesh.
  160. Clinical evaluation of injectable biodegradable contraceptive system.
  161. Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and d-norgestrel.
  162. Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and d-norgestrel.
  163. Coagulation factors in women using oral contraceptives or intrauterine contraceptive devices immediately after abortion.
  164. Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. 1. Carbohydrate metabolism and liver function.
  165. Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. 2. Serum lipoproteins and apolipoproteins.
  166. Complications of pregnancy and labor in former oral contraceptive users.
  167. Contraception and abortion in Poland.
  168. Contraception and abortion in Poland.
  169. Contraceptive availability differentials in use and fertility.
  170. Contraceptive practices of, and advice received by, female patients being treated by haemodialysis.
  171. Contraceptive use and family planning services along the U. S.-Mexico border.
  172. Contraceptives and the conceptus. Pt. 2. Sex of the fetus and neonate after oral contraceptive use.
  173. Contraceptives and the female undergraduates in Ibadan, Nigeria.
  174. Correlates of contraceptive use among urban poor in Colombia.
  175. Cost-benefit and cost-effectiveness analysis for family planning programs.
  176. The costs and benefits of government expenditures for family planning programs.
  177. A cross-cultural study of menstruation: implications for contraceptive development and use.
  178. Cytologic studies after insertion of intrauterine contraceptive devices (IUD) (author's transl) [Zytologische Befunde beim Intrauterinpessar.]
  179. Dermal changes in response to hormonal contraceptives (author's transl) [Hautveranderungen bei hormonellen Antikonzeptiva.]
  180. Desired family size and contraceptive use: an 11-country comparison.
  181. Does gonorrhoea exist in family planning clinics?
  182. The effect of a contraceptive vaginal ring and oral contraceptives on the vaginal flora.
  183. The effect on lipids and lipoproteins of a contraceptive vaginal ring containing levonorgestrel and estradiol.
  184. Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen: controlled double-blind investigation.
  185. Effects of angiotension 2 analog on blood pressure, renin and aldosterone in women on oral contraceptives and toxemia.
  186. Evaluation of contraceptive knowledge of community-based distributors in Guatemala.
  187. Extragenital changes caused by intake of hormonal contraceptives: marginal periodontium (author's transl) [Extragenitale Veranderungen durch hormonale Kontrazeptiva am marginalen Periodent.]
  188. Factors associated with family planning acceptance in Bangkok metropolis health clinic areas (MHCs)
  189. Family planning attitudes in urban Indonesia: findings from focus group research.
  190. Family planning in the 1980's: challenges and opportunities.
  191. Family planning practices among Anglo and Hispanic women in U.S. counties bordering Mexico.
  192. Family size and family planning in Kenya: continuity and change in metropolitan and rural attitudes.
  193. Fertility and contraception in 12 developed countries.
  194. Fertility and family planning in the South Pacific.
  195. Fertility differences and the need for family planning services in five Latin American countries.
  196. Fibrinolytic response and oral contraceptive associated thromboembolism.
  197. Flow properties of blood in women on oral contraceptives (author's transl) [Die Fliessfahigkeit des Blutes unter Einnahme von Ovulationshemmern.]
  198. Focus group and survey research on family planning in Mexico.
  199. Four years of experience with the TCu 380A intrauterine contraceptive device.
  200. Further studies on pituitary and ovarian function in women receiving hormonal contraception.
  201. Health and family planning services in Bangladesh: a study in inequality.
  202. Hormonal contraceptives of differentiated composition: effects on thrombocyte function (author's transl) [Beeinflussung der thrombozytenfunktion durch hormonale kontrazeptiva unterschiedlicher zusammensetzung.]
  203. The impact of early use of prescription contraceptives on reducing premarital teenage pregnancies.
  204. The impact of family planning clinic programs on adolescent pregnancy.
  205. The impact of the female marriage squeeze and the contraceptive revolution on sex roles and the women's Liberation Movement in the United States, 1960 to 1975.
  206. Inflammatory disease associated with oral contraceptive use [letter]
  207. Injectable contraception. [Letter]

     

  208. Injectable contraception. [Letter]
  209. Injectable contraception. [Letter]
  210. Injectable contraception. [Letter]
  211. Knowledge of contraceptives: an assessment of World Fertility Survey data collection procedures.
  212. Levonorgestrel and estradiol release from an improved contraceptive vaginal ring.
  213. Lipoprotein patterns in women in Santo Domingo using a levonorgestrel/estradiol contraceptive ring.
  214. Liver tumours in pregnancy, following previous intake of hormonal contraceptives (author's transl) [Lebertumoren in der Schwangerschaft nach Einnahme hormonaler Kontrazeptiva.]
  215. Long-term contraception with a single implant of the progestin ST-1435.
  216. A low-dose combination oral contraceptive: experience with 1,700 women treated for 22,489 cycles.
  217. Low-dose oral contraceptive usage and coagulation.
  218. Menstrual blood loss with contraceptive subdermal levonorgestrel implants.
  219. A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. I. Use effectiveness. An international comparative trial.
  220. A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. II. Subjective and objective measures of effects. An international comparative trial.
  221. A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. III. Menstrual patterns. An international comparative trial.
  222. The Multiload intra-uterine contraceptive device. Comparison of 4 different models.
  223. Multivariate relationships between modernity value orientations and family planning indicators.
  224. Natural family planning: postpartum period.
  225. New results in connection with the problem of a connection between oral contraception and vaginal yeast. A two-year prospective, epidemiologic study of 8314 patients. [Neue Ergebnisse zur Frage eines Zusammenhanges zwischen oraler Kontrazeption und vaginalem Sprosspilzbefall. Eine prospektive epidemiologische Zweijahresstudie an 8314 Patientinnen.]
  226. The nurse practitioner in Planned Parenthood clinics.
  227. Occurrence, frequency and management of oral contraceptive associated liver tumors.
  228. On the dispersion capacity of an intra-vaginal contraceptive ovule: results of an in-vivo study in sexually not stimulated women (author's transl) [Zur frage des Dispersionsvermogens eines intravaginalen kontrazeptiven Ovulum.]
  229. Oral contraception and myocardial infarction revisited: the effects of new preparations and prescribing patterns.
  230. Oral contraception in diabetic women. Diabetes control, serum and high density lipoprotein lipids during low-dose progestogen, combined oestrogen/progestogen and non-hormonal contraception.
  231. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
  232. Oral contraceptives and postmolar trophoblastic disease.
  233. Oral contraceptives: where are the excess deaths [letter]
  234. Oral contraceptives: where are the excess deaths?
  235. Oral steroid contraception in hyperprolactinemia (author's transl) [Steroidkontraception und hyperprolaktinamie.]
  236. Pain response following insertion of a Gravigard (Copper-7) intrauterine contraceptive device in nulliparous women.
  237. Parent and peer influence on sexual behavior, contraceptive use, and pregnancy experience of young women.
  238. The Pearl Pregnancy Index reexamined: still useful for clinical trial of contraceptives.
  239. Perception of methods of contraception: a semantic differential study.
  240. Pituitary response to LHRH stimulation in women on oral contraceptives: a followup dose response study.
  241. Plasma levels of ethinylestradiol (EE) during cyclic treatment with combined oral contraceptives.
  242. Polygyny and family planning in sub-Saharan Africa.
  243. Population learning among rural Turkish youth from an adult-oriented family planning program.
  244. Premarital sexual guilt and contraceptive attitudes and behavior.
  245. Premenstrual complaints. II. Influence of oral contraceptives.
  246. The progestogen only contraceptive pill in insulin dependent diabetics.
  247. Prudah and family planning in Pakistan.
  248. Psychic attitude of women to irreversible contraception (author's transl) [Zur psychischen Verarbeitung der irreversiblen Kontrazeption bei der Frau.]
  249. The R.C.G.P. Oral Contraception Study. [Letter]
  250. A randomized study of metabolic effects of four low-estrogen oral contraceptives: 1. Results after 6 cycles.
  251. Reduced menstrual blood loss by release of an antifibrinolytic agent from intrauterine contraceptive devices.
  252. The relation between oral contraceptive use and subsequent development of hyperprolactinemia.
  253. Research utilization in Taiwan's family planning program.
  254. The return of fertility following discontinuation of oral contraceptives in Thailand.
  255. Self-concept and contraception: pre-conception decision-making.
  256. Serum-25-hydroxycholecalciferol levels in women using oral contraceptives.
  257. Sex behaviour and contraceptive use among socioeconomic groups of young women in the United States.
  258. Status of the reproductive system in women taking oral contraceptives for a long time (author's transl) [Sostoianie reproduktivnoi sistemy zhenshehin, dlitel'no prinimaiushehikh oral'nye kontratseptivy.]
  259. Studies on ovarian and adrenal steroids at different phases of the menstrual cycle: 3. Steroid and lutropin levels before and after the administration of a single contraceptive dose of depot-medroxyprogesterone (DMPA)
  260. A study of contraceptive choice and use in Bangkok metropolis health clinics.
  261. Trends in cardiovascular disease mortality and oral contraceptives.
  262. Trends in fertility, family size preferences, and family planning practice: Taiwan, 1961-80.
  263. Twinning following oral contraceptive discontinuation.
  264. Unusual presentation of translocated intrauterine contraceptive device. [Letter]
  265. Uptake of contraceptive services -- implications for training.
  266. Use of a contraceptive suppository as chemoprophylaxis against sexually-transmitted diseases. [El uso de un ovulo anticonceptivo como quimioprofilactico de las enfermedades sexualmente transmisibles.]
  267. Use of modern contraceptives in Indonesia: a challenge to the conventional wisdom.
  268. Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives.
  269. The Walnut Creek contraceptive drug study.
  270. Films for family planning programs./Filmes para programas de planejamento familiar./Films pour programmes de planning familial./Peliculas para programas de planificacion familia.r.
  271. Breast-feeding, fertility, and family planning./L'Allaitement au sein, la fecondite et le planning famililal./Amamentacao, fecundidade e planejamento familiar./La lactancia materna, la fecundidad y la planificacion familiar.
  272. Contraceptive prevalence surveys: a new source of family planning data./Pesquisas sobre saude materno-infantil e planejamento familiar: uma nova fonte de dados sobre o planejamento familiar./Enquetes sur la prevalence de la contraception : source nouvelle de donnees sur le planning familial./Las encuestas de prevalencia del uso de anticonceptivos : una nueva fuente de datos sobre planificacion familiar.
  273. The injectable contraceptive, DMPA, serum HDL cholesterol and myocardial infarction (author's transl) [Prikpil, serum-HDL-cholesterol en hartinfarct.]
  274. Institutionalization of integrated family planning concepts into home economics [news release]
  275. Integrated family planning activities in maternal and child health centres in Cap Bon, Tunisia. 1. Methodology and results.
  276. Integrated family planning activities in maternal and child health centres in Cap Bon, Tunisia. 2. Use of a family planning technical card in an integrated maternal and child health program.
  277. Integrated family planning activities in maternal and child health centres in Cap Bon, Tunisia. Part III: impact on some maternal and child health indicators.
  278. The integrated family planning-nutrition program: a new approach to self-reliance.
  279. The integrated MCH-family planning development project in Mojokerto, East Java: a summary of experiences and results.
  280. The integrated MCH-family planning development project in Mojokerto, East Java: a summary of experiences and results.
  281. Integrated Program of Intestinal Parasite Control. Family Planning and Nutrition. Yearly report, 1980, Foundation for Population Studies, Mexico.
  282. Integrated project of family planning and parasite control in Oeiras.
  283. The integrated project on family planning, parasite control and nutrition in the Philippines: country report.
  284. Integration of family planning with health care.
  285. The interaction of cigarette smoking, oral contraceptive use and cardiovascular risk factor variables in children -- the Bogalusa Heart Study.
  286. Interactions between contraceptive pills and other drugs.
  287. Interference with epididymal physiology as possible site of male contraception.
  288. Interindividual variation and drug interactions with hormonal steroid contraceptives.
  289. International Conference on Family Planning in the 1980s: recommendations and implications.
  290. International overview of contraceptive research.
  291. The international politics of contraception.
  292. International standardization of contraceptives. Memorandum ISO/TC 157.
  293. International Symposium on the Use of Contraceptives in Egypt: summary and recommendations.
  294. Interrelationship between oral contraceptives and some parameters of the coagulative-fibrinolytic function (author's transl) [Interrelazioni fra estroprogestinici ed alcuni parametri della funzione coagulativa-fibrinolitica.]
  295. Intra uterine device: an analysis of reasons for discontinuation at a family planning clinic.
  296. Intrauterine contraception from the viewpoint of an ambulatory gynecologic department. [Intrauterine Kontrazeption aus der Sicht einer ambulanten gynakologischen Abteilung.]
  297. Intrauterine contraception in nulliparas with Nullip.
  298. Intrauterine contraception using the Copper Mini-Gravigard 7 IUD: summary of 328 case histories.
  299. Intrauterine contraception with copper-T 200 device-a retrospective analysis of 354 cases (author's transl) [Intrauterine Kontrazeption mit dem Kupfer-T-200 Pessareine retrospektive Analyse an Hand von 334 Einlagen.]
  300. Intrauterine contraception with levonorgestrel: comparative randomized clinical performance study.
  301. Intrauterine contraceptive device failures in renal transplant patients.
  302. Intrauterine contraceptive devices and actinomycosis. [Intrauteriene kontraseptiewe toestelle en aktinomikose.]
  303. The intrauterine device--provider consumer attitudes in Sri Lanka: a report of a study conducted by the Family Planning Association of Sri Lanka.
  304. Introducing ICSMP, The International Contraceptive Social Marketing Project.
  305. Introducing nutrition services with family planning clinics.
  306. Introduction of the CPS (Contraceptive Prevalence Survey) by USAID. Some perspectives on the Contraceptive Prevalence Surveys and on the future of survey research. [Introduccion de la EPA por USAID. Algunas perspectivas sobre las encuestas de prevalencia del uso de anticonceptivos y sobre el porvenir de las investigaciones por medio de encuestas.]
  307. Access and availability issues in contraceptive failures.
  308. Accessibility and availability of family planning in Thailand.
  309. Actinomyces in the vaginas of women with and without intrauterine contraceptive devices.
  310. Actinomyces-like organisms in cervical smears from women using intrauterine contraceptive devices [letter]
  311. Actinomyces-like structures and their association with intrauterine contraceptive devices, pelvic infection and abnormal cervical cytology.
  312. Action of medicated intrauterine contraceptives on the endometrium. [O vozdeistvii medikamentoznykh vnutrimatochykh kontratseptivov na endometrii.]
  313. An action research on the promotion of conventional methods of contraceptives among Egyptian married couples.
  314. Acute damage to the digestive tract related to contraceptives (author's transl) [Les accidents digestifs aigus des contraceptifs.]
  315. Adenocarcinoma of the endometrium while undergoing contraceptive treatment with medroxyprogesterone. [Adenocarcinome de l'endometre sous traitement contraceptif par medroxyprogesterone.]
  316. The adolescent and contraception.
  317. The adolescent and contraception: issues and controversies.
  318. Adolescent contraception.
  319. Adolescent contraception.
  320. Adolescent contraception. [La contraception a l'adolescence.]
  321. Adolescent peers as facilitators of contraceptive use.
  322. Adolescent perceptions of personal and ecological factors predicting contraceptive use: a multilevel multivariable study.
  323. Adopters and non-adopters of family planning in an Indian village: a case study.
  324. Adult education community projects and Planned Parenthood: a study of an inter-agency project in Honduras, Central America.
  325. An African view of family planning problems.
  326. Age-specific secular changes in oral contraceptive use [letter]
  327. Agency policy regarding natural family planning.
  328. Agenda for the "sexual revolution:" abortion, contraception, sex education and related evils.
  329. Alcohol: the ultimate birth control drug.
  330. Alternatives to adolescent pregnancy: a discussion of the contraceptive literature from 1960 to 1980.
  331. Alternatives to clinic-based family planning programs.
  332. Amenorrhea occurring after the discontinuation of oral contraceptive usage. [L'amenorrhee post-pilule.]
  333. American public opinion toward sex education and contraception for teenagers.
  334. Analysis of attitudes of Oklahomans of voting age toward sex education, teen contraception, and abortion.
  335. The analysis of cross-method variance in assessing family planning programme effects on fertility.
  336. The analysis of efficiency of family planning programs.
  337. Anomaly of the fertility decline in Kerala: social change, agrarian reform, or the family planning program?
  338. Wang Renzhong, Chen Muhua stress family planning.
  339. We must seriously study the new situation in family planning.
  340. WFS Philippines: more than half of all women at risk of pregnancy use no contraceptive method.
  341. What has this to do with working class women?: birth control and the Canadian left, 1900-1939.
  342. What price contraception? [editorial]
  343. What value (risks) do today's modern possibilities of contraception have? [Welche Wertigkeit (Risiken) haben heute die modernen Moglichkeiten der Kontrazeption?]
  344. Whatever happened to new methods of birth control?
  345. Who says oral contraceptives are safe?
  346. Why Islam permitted birth control.
  347. Why the world is not getting the contraception it needs.
  348. Why they delay: a study of teenage family planning clinic patients.
  349. Why women don't use contraception.
  350. Women time allocation and adoption of family planning practices in farm family.
  351. Women's attitudes regarding fertility and use of contraceptives methods. [Actitudes de la mujer frente a la fecundidad y uso de metodos anticonceptivos.]
  352. Women's involvement in socioeconomic projects related to family planning.
  353. Women-to-women delivery systems for family planning.
  354. World Federation policy statement. I. The health rationale for voluntary surgical contraception.
  355. World Federation policy statement. II. Suggested guiding principles for legislation and administrative regulation of voluntary surgical contraception.
  356. World Federation policy statement. III. The use of paramedicals in voluntary surgical contraception education and service delivery.
  357. World Federation policy statement. IV. Incentives and disincentives relating to voluntary surgical contraception.
  358. Xinjiang family planning.
  359. Yoruba traditional healers' knowledge of contraception, abortion and infertility.
  360. Zinc and copper nutriture of women taking oral contraceptive agents.
  361. A 10-year comparison of post-oral contraceptive amenorrhea with amenorrhea unrelated to use of drugs.
  362. 1881-1981: a century of organized family planning in the Netherlands.
  363. 1980 Lagos Contraception and Breastfeeding Study [tables]
  364. 1981 directory of contraceptives. [1981 repertoire des contraceptifs.]
  365. A 2 country experience: the integration of family planning and population education in community-based development programs through the social work method.
  366. Abortion and contraception in relation to family planning services.
  367. Abortion and contraception.
  368. Abstinence as a method of birth control: fertility and child-spacing practices among rural Yoruba women of Nigeria.
  369. Acceptability and continuation of injectable contraceptives in Bangladesh.
  370. The acceptability of vaginal contraception.

     

  371. Acceptance of natural family planning methods in Colombia.
  372. Antecedents affecting contraceptive behavior of teenage females.
  373. Anthropological approach in fertility and family planning research in Korea.
  374. Anti-planned parenthood activities denounced.
  375. An anti-spermatozoon contraceptive: the ST film.
  376. Antibiotics and oral contraceptives. [Letter]
  377. Appendiceal perforation by Copper-7 intrauterine contraceptive device.
  378. Appendix 1. Contraindications to estrogen-containing birth control pills.
  379. Application of the casework method in changing the positive attitudes towards family planning into actual practice: an experimental study on El-Nasr Factory for Textile in Embaba, Egypt.
  380. Approved list of contraceptives based on available data on efficacy and acceptability.
  381. Arterial hypertension from the contraceptive pill: general review based on 39 personal observations. [L'hypertension arterielle de la pilule contraceptive: revue generale a propos de 39 observations personnelles.]
  382. Asia Contraceptive Prevalence Surveys Regional Workshop Proceedings, Pattaya, Thailand, February 16-20, 1981.
  383. Aspects of reproduction related to human rights. II. Contraception. [Aspectos de la reproduccion relacionados con los derechos humanos. II. Anticoncepcion.]
  384. An assessment of fertility and contraception in seven Philippine provinces: 1975.
  385. Atheromatous mesenteric occlusion associated with oral contraceptives and cigarette smoking.
  386. Attitude towards introduction of abortion as a method of family planning in Bangladesh.
  387. Attitudes of college students toward use of the pharmacist as a contraceptive counselor.
  388. The attitudes of religious (Santri) youth in Madura towards family planning.
  389. Attitudes toward male oral contraceptives: implications for models of the relationship between beliefs and attitudes.
  390. Atypical reserve cell hyperplasia of cervical glands, simulating adenocarcinoma. An undescribed reversible lesion in a woman taking oral contraceptives.
  391. Automatic assay of circulating immune complexes induced by oral contraceptives (author's transl) [Depistage automatique des complexes immuns circulants induits par les hormones contraceptives.]
  392. Bangladesh contraceptive prevalence survey report - 1979.
  393. Bangladesh Contraceptive Prevalence Survey report-1979.
  394. Bangladesh Contraceptive Prevalence Survey--1981 [tables]
  395. Barrier contraception: a comprehensive overview.
  396. The benefit of the classification of oral contraceptives: studies of 525 women taking oral contraceptives (author's transl) [Nutzen der Klassifikation hormonaler Kontrazeptiva: studie an 525 Frauen unter hormonaler Kontrazeption.]
  397. Benefits of integrating family planning with health services: the Narangwal experiment.
  398. Bibliography on population and family planning in Korea. Supplement 3.
  399. Bile acid kinetics in pregnancy and in women receiving contraceptive steroids (CS)
  400. Binding of a contraceptive progestogen ORG 2969 and its metabolites to receptor proteins and human sex hormone binding globulin.
  401. Binding of the contraceptive steroids medroxyprogesterone acetate and ethynyloestradiol in blood of various species.
  402. Birth control and late marriage.
  403. Birth control and the fertility of the U. S. black population, 1880 to 1980.
  404. Birth control in China: local data and their reliability.
  405. Birth control in Spain. [Control de natalidad en Espana.]
  406. Birth control in the year 2001.
  407. Birth control is a labor-saving device. Pt. 2.
  408. Birth control practice in Khartoum.
  409. Birth control--sex preference and sex ratio.
  410. Birth control: contraception. [Controllo delle nascite: contraccezione.]
  411. Birth control: lay challenge to medical authority over childbirth.
  412. Birthspacing, fertility, and family planning: policy and program implications from the Malaysian Family Life Survey.
  413. Black Africa: population, development and family planning in Africa south of the Sahara.
  414. Black family planning: attitudes of leaders and a general sample.
  415. Blocking family planning.
  416. Blood glucose and plasma insulin studies during three months use of a low-estrogen type oral contraceptive.
  417. The blood-serum iron concentrations in women applying Anagravid (Polfa) preparation as contraceptive means (author's transl) [Zachowanie sie poziomu zelaza w surowicy krwi kobiet stosujacych preparat Angravid--Polfa w celach antykoncepcyjnych.]
  418. Bloodless determination of the partial pressure of oxygen in the gingiva as a longitudinal study conducted in the case of administration of hormonal contraceptives (author's transl) [Unblutige Sauerstoffpartialdruckbestimmung an der Gingiva als Langsschnittstudie bei Anwendung hormoneller Kontrazeptiva.]
  419. Body image of and contraceptive use by college females.
  420. Brazil cautiously begins national family planning program.
  421. Breast cancer and oral contraceptives: findings in Oxford-Family Planning Association contraceptive study.
  422. Breast cancer and oral contraceptives: findings in Royal College of General Practitioners' study.
  423. Breast cancer and use of antihypertensive drugs and oral contraceptives: results of a case-control study (author's transl) [Etude de la liaison entre le cancer du sein et la prise de medicaments hypotenseurs et contraceptifs oraux: resultats d'une etude cas-temoins.]
  424. Breast feeding and oral contraceptives. [Borstvoeding en orale anticonceptie.]
  425. Breast-feeding and contraception.
  426. Breastfeeding and family planning: meaningful integration of services.
  427. Brief guidelines for designing an integrated family planning and parasite control project.
  428. A brief note on rubber technology and contraception: the diaphragm and the condom.
  429. Bringing in the family: kinship support and contraceptive behavior.
  430. Budd-Chiari Syndrome and hepatic adenomas associated with oral contraceptives. A case report.
  431. Buserelin: contraception through nasal spray.
  432. Caffeine and oral contraceptives. [Caffeina ed anticoncezionali orali.]
  433. Calls for reinvigorating India's Family Planning Program.
  434. The campaign to encourage family planning in Tunisia and some responses at the village level.
  435. Carbohydrate and lipid metabolism in women using oral contraceptives. [Sostoianie uglevodnogo i lipidnogo obmena u zhenshchin pri primenenii kombinirovannykk oralnykh kontratseptivov.]
  436. Cardiovascular side-effects of oral contraceptives with special regard to metabolism, lipoproteins and their role in the pathogenesis of vascular complications (author's transl) [Nebenwirkungen der hormonalen Kontrazeption: Einfluss auf Gefasssystem und Blutgerinnung, metabolische Wirkungen und Fettstoffwechsel.]
  437. In case of a request for "the morning after" pill. Do's and don'ts. [Devant une demande de contraception "du lendemain". Faites...ne faites pas.]
  438. In case of a request for contraception in the perimenopause; do's and don'ts. [Devant une demande de contraception a la perimenopause: faites... ne faites pas.]
  439. A case of hepatoma in pregnancy associated with earlier oral contraception.
  440. Case of tubo-ovarian abscesses with peritonitis and septic shock in a patient wearing an intrauterine contraceptive device. [Przypadek ropniakow jajowodowo-jajnikowych z zapaleniem otrzewnej i wstrzasem septycznym u chorej z wewnatrzmaciczna wkladka antykoncepcyjna.]
  441. A case report of hemolytic uremic syndrome by an oral contraceptive, and its clinical and pathological reviews (author's transl)]
  442. Cerebral circulatory disorders while taking contraceptives. [Narusheniia mozgovogo krovoobrashchenia pri upotreblenii kontraseptivnykh sredstv.]
  443. Cerebrovascular and migraine episodes related to prolonged oral contraception (author's transl) [Osservazioni su un caso di episodi cerebrovascolari multipli ed emicranici da uso di contraccettivi orali.]
  444. Certain psychological correlates of contraceptive behavior among women.
  445. Cervical and vaginal cytology during contraception by IUD. [Zervix- und Vaginalzytologie unter IUD-Prophylaxe.]
  446. The cervical cap: an alternative contraceptive.
  447. Cervical caps: the perfect, untested contraceptive.
  448. Changed attitudes to birth control.
  449. Changes in acceptability of different contraceptives in the last five years.
  450. Changes in acceptability of different contraceptives.
  451. Changes in China's family planning programs.
  452. Changes in menstrual cycle parameters with prolonged use of intrauterine device for contraceptive purposes. [Izmeneniia v niakoi parametri na menstrualniia tsikul pri produlzhitelno izpolzuvane na vutrematochen pesar s kontraseptivna tsel.]
  453. Changes in serum beta-thromboglobulin levels during oral contraception, cardiac valve disease and pulmonary embolism. [Variations de la beta thromboglobuline au cours de la contraception orale, des valvupathies appareillees ou non, et de l'mbolie pulmonaire.]
  454. Changes in the metabolic cost of standardized work associated with the use of an oral contraceptive.
  455. Changes in thyroid function in pregnancy and with oral contraceptive use.
  456. Changing contraceptive usage intentions: a test of the Fishbein model of intention.
  457. Changing patterns in the use of family planning: evidence from a worldwide program of contraceptive prevalence surveys.
  458. Changing patterns of contraception.
  459. Characteristics of teenagers at contraception, abortion, and prenatal clinics.
  460. Chen Muhua gives radio talk on family planning.
  461. Chen Muhua holds meeting on contraceptives.
  462. China considers stricter birth control law to replace unevenly applied measures.
  463. Chinese contraceptive methods.
  464. Chorea associated with the use of oral contraceptives: report of a case and review of the literature.
  465. Choreic syndrome following intramuscular application of a contraceptive preparation (author's transl) [Ein choreatisches Syndrom nach intramuskulaerer Applikation eines Kontrazeptivums.]
  466. Chronic treatment with a LH-RH-agonist: a new contraceptive method?
  467. Chronology of population and family planning activities in China.
  468. Clinical laboratory evaluation of a low-estrogen combination oral contraceptive.
  469. Clinical pharmacology and common minor side effects of oral contraceptives.
  470. Clinical study of gossypol as a male contraceptive.
  471. Clinical study of the new progesterone intrauterine device for birth control (author's transl) [Osservazioni sul nuovo dispositivo intrauterino al progestrone per il controllo della riproduzione.]
  472. Collaboration between the public and private sectors in population/family planning.
  473. Colposcopic study of the effect of steroid contraceptives on the uterine cervix.
  474. Community availability of contraceptives and family limitation.
  475. Community based distribution of contraception: a review of field experience.
  476. Community family planning in Haiti. [Planificacion familiar de comunidades de Haiti.]
  477. Community family planning services in IPPF.
  478. A comparative study on the input-output relationships of family planning programmes in selected countries of the ESCAP region: measures of planning evaluation programmes.
  479. Comparing subsequent birth control activities of women undergoing induced abortion and of other family planning clients.
  480. Comparison of cause of death coding on death certificates with coding in the Royal College of General Practitioners Oral Contraception Study.
  481. A comparison of the cost-effectiveness of different types of service delivery posts in the BEMFAM FAmily Planning Planning Program in Piaui State, Brazil.
  482. A comparison of unwed pregnant teenagers and nulligravid sexually active adolescents seeking contraception.
  483. Complete regression of hepatocellular adenoma after withdrawal of oral contraceptives.
  484. Complications after insertion of intrauterine contraceptive devices. [Komplikationen nach einlage kontrazeptiv wirksamer pessare.]
  485. Complications and contraindications of oral contraception.
  486. A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate.
  487. A comprehensive review of the objectives, activities and performance of the family planning programs of the United Nations Fund for Population Activities.
  488. Computerized patient-flow analysis of local family planning clinics.
  489. Concurrent oral contraceptive and antibiotic therapy [answer to Robert L. Devine's question]
  490. The condom as contraceptive and prophylactic--a reappraisal.
  491. Consent to sterilization as a contraceptive method. [Le consentement a la sterilisation comme moyen de contraception.]
  492. Consumer demand and marketing action plans for family planning in Bangladesh.
  493. The continuing need for contraceptive research [editorial]
  494. Continuity and change in metropolitan and rural attitudes towards family size and family planning in Kenya between 1966/1967 and 1977/1978.
  495. Continuously do a good job in planned parenthood work and fulfill this year's population target.
  496. Contraception after 40 years old (author's transl) [La contraception apres 40 ans.]
  497. Contraception and female sterilization.
  498. Contraception and lactation.
  499. Contraception and pelvic inflammatory disease.
  500. Contraception and population trends.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.